
NaviFUS Corp. 6872.TWO
6872.TWO
NaviFUS Corp. 6564.TWO
Enimmune corporation 6810.TWO
Bio Preventive Medicine Corp. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 6814.TWO
Lukas Biomedical Inc. 6876.TWO
LAUNXP Biomedical Co., Ltd 4194.TWO
Holy Stone Healthcare Co., Ltd. 7725.TWO
LabTurbo Biotech Corporation 4131.TWO
NeoCore Technology Co., Ltd. 6850.TWO
BiOptic Inc.
NaviFUS Corp. 6564.TWO
Enimmune corporation 6810.TWO
Bio Preventive Medicine Corp. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 6814.TWO
Lukas Biomedical Inc. 6876.TWO
LAUNXP Biomedical Co., Ltd 4194.TWO
Holy Stone Healthcare Co., Ltd. 7725.TWO
LabTurbo Biotech Corporation 4131.TWO
NeoCore Technology Co., Ltd. 6850.TWO
BiOptic Inc.
Performance
Periode | 6872.TWO | 6564.TWO | 6810.TWO | 7427.TWO | 6814.TWO | 6876.TWO | 4194.TWO | 7725.TWO | 4131.TWO | 6850.TWO |
---|---|---|---|---|---|---|---|---|---|---|
6M | -15.03 % | 11.44 % | 2.13 % | -15.28 % | 12.60 % | 41.76 % | 33.47 % | 2.49 % | -3.28 % | 19.08 % |
YTD | -26.80 % | -15.69 % | -20.00 % | -9.48 % | -6.26 % | 21.11 % | -22.51 % | -5.54 % | 1.57 % | 18.66 % |
1Y | -29.83 % | -35.44 % | -22.71 % | -12.90 % | -6.10 % | 40.12 % | -41.65 % | -9.19 % | 8.36 % | 3.30 % |
3Y | -2.49 % | -56.17 % | -30.41 % | -2.66 % | -8.28 % | 7.59 % | -49.66 % | -38.10 % | 47.27 % | 58.89 % |
5Y | -16.36 % | -57.39 % | 15.89 % | -45.35 % | -46.64 % | 7.59 % | -26.89 % | -38.10 % | 51.76 % | 17.24 % |
10Y | -16.36 % | -35.22 % | 15.89 % | -45.35 % | -46.64 % | 7.59 % | -68.13 % | -38.10 % | 69.99 % | 17.24 % |
From the beginning | -16.36 % | -35.22 % | 15.89 % | -45.35 % | -46.64 % | 7.59 % | -90.67 % | -38.10 % | -77.40 % | 17.24 % |